Patents Assigned to Medical Corporation Ichikawa Clinic
  • Method for preparing cell extract component or composition having cytocidal activity
    Patent number: 11963978
    Abstract: Provided is a method or the like for producing a composition exhibiting cytocidal activity. This method for producing a composition exhibiting cytocidal activity comprises: culturing malignant tumor-derived cells in a culture medium at least until the cell density reaches a level that does not pose a problem for transfer; replacing, after culturing, the culture medium with a physiological buffer salt solution; and recovering the physiological buffer salt solution after death of the malignant tumor-derived cells is observed morphologically in the physiological buffer salt solution.
    Type: Grant
    Filed: September 9, 2021
    Date of Patent: April 23, 2024
    Assignee: Medical Corporation Ichikawa Clinic
    Inventors: Tomoyuki Tajima, Yoshifusa Kondo
  • Method for preparing cell extract component or composition having cytocidal activity
    Patent number: 11318162
    Abstract: Provided is a method or the like for producing a composition exhibiting cytocidal activity. This method for producing a composition exhibiting cytocidal activity comprises: culturing malignant tumor-derived cells in a culture medium at least until the cell density reaches a level that does not pose a problem for transfer; replacing, after culturing, the culture medium with a physiological buffer salt solution; and recovering the physiological buffer salt solution after death of the malignant tumor-derived cells is observed morphologically in the physiological buffer salt solution.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: May 3, 2022
    Assignee: Medical Corporation Ichikawa Clinic
    Inventors: Tomoyuki Tajima, Yoshifusa Kondo
  • METHOD FOR PREPARING CELL EXTRACT COMPONENT OR COMPOSITION HAVING CYTOCIDAL ACTIVITY
    Publication number: 20210401882
    Abstract: Provided is a method or the like for producing a composition exhibiting cytocidal activity. This method for producing a composition exhibiting cytocidal activity comprises: culturing malignant tumor-derived cells in a culture medium at least until the cell density reaches a level that does not pose a problem for transfer; replacing, after culturing, the culture medium with a physiological buffer salt solution; and recovering the physiological buffer salt solution after death of the malignant tumor-derived cells is observed morphologically in the physiological buffer salt solution.
    Type: Application
    Filed: September 9, 2021
    Publication date: December 30, 2021
    Applicant: Medical Corporation Ichikawa Clinic
    Inventors: Tomoyuki TAJIMA, Yoshifusa KONDO
  • METHOD FOR PREPARING CELL EXTRACT COMPONENT OR COMPOSITION HAVING CYTOCIDAL ACTIVITY
    Publication number: 20200222458
    Abstract: Provided is a method or the like for producing a composition exhibiting cytocidal activity. This method for producing a composition exhibiting cytocidal activity comprises: culturing malignant tumor-derived cells in a culture medium at least until the cell density reaches a level that does not pose a problem for transfer; replacing, after culturing, the culture medium with a physiological buffer salt solution; and recovering the physiological buffer salt solution after death of the malignant tumor-derived cells is observed morphologically in the physiological buffer salt solution.
    Type: Application
    Filed: October 5, 2018
    Publication date: July 16, 2020
    Applicant: Medical Corporation Ichikawa Clinic
    Inventors: Tomoyuki TAJIMA, Yoshifusa KONDO